Jonathan Van-Tam
#17,400
Most Influential Person Now
British influenza researcher
Jonathan Van-Tam's AcademicInfluence.com Rankings
Jonathan Van-Tammedical Degrees
Medical
#268
World Rank
#397
Historical Rank
Epidemiology
#206
World Rank
#220
Historical Rank
Jonathan Van-Tamphilosophy Degrees
Philosophy
#7031
World Rank
#10178
Historical Rank
Logic
#6982
World Rank
#8571
Historical Rank
Download Badge
Medical Philosophy
Jonathan Van-Tam's Degrees
- Masters Medicine University of Nottingham
- Masters Epidemiology University of Nottingham
- PhD Microbiology University of Nottingham
Why Is Jonathan Van-Tam Influential?
(Suggest an Edit or Addition)According to Wikipedia, Professor Sir Jonathan Stafford Nguyen Van-Tam is a British healthcare professional specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness.
Jonathan Van-Tam's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study (2020) (2363)
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis (2014) (927)
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score (2020) (590)
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. (2014) (531)
- Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study (2020) (451)
- Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (397)
- Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study (2014) (356)
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial (2021) (297)
- SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review (2020) (293)
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial (2021) (275)
- Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) (2010) (261)
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum (2021) (247)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2019) (241)
- Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study. (2015) (215)
- Middle East Respiratory Syndrome. (2017) (211)
- Reduction in mortality associated with influenza vaccine during 1989-90 epidemic (1995) (208)
- The epidemiology and clinical impact of pandemic influenza. (2003) (199)
- Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009–2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients (2012) (191)
- Routes of influenza transmission (2013) (186)
- Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. (2013) (155)
- Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study (2021) (155)
- Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study (2000) (144)
- The roles of transportation and transportation hubs in the propagation of influenza and coronaviruses: a systematic review (2016) (142)
- Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. (2013) (140)
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study (2021) (136)
- Healthcare workers' willingness to work during an influenza pandemic: a systematic review and meta-analysis (2015) (134)
- Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. (2012) (129)
- Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults (2022) (120)
- Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic – The Risk of Aerosol Generation during Medical Procedures (2013) (120)
- Bacterial Pneumonia and Pandemic Influenza Planning (2008) (118)
- Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. (2006) (117)
- Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis. (2019) (115)
- Guidance on the use of respiratory and facial protection equipment (2013) (114)
- Dynamics of Meningococcal Long-Term Carriage among University Students and Their Implications for Mass Vaccination (2000) (109)
- Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial (2021) (108)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2016) (107)
- Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma (1998) (102)
- Emergency (999) calls to the ambulance service that do not result in the patient being transported to hospital: an epidemiological study (2002) (102)
- Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review (2014) (99)
- Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). (2013) (99)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- Influenza in long‐term care facilities (2017) (96)
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK (2021) (94)
- Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review (2016) (87)
- Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control (2011) (87)
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. (2011) (86)
- Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients (2020) (84)
- Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases (2010) (81)
- Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK (2012) (79)
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021) (77)
- Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (2018) (72)
- Edinburgh Research Explorer Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study (2020) (72)
- Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. (2015) (69)
- Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe (2017) (69)
- Personal protective equipment in an influenza pandemic: a UK simulation exercise. (2009) (65)
- Results of inguinal canal repair in athletes with sports hernia. (2002) (64)
- Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis (2017) (60)
- Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation (1999) (58)
- Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010 (2011) (57)
- Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis (2015) (57)
- Neuraminidase inhibitors: who, when, where? (2015) (57)
- Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease (2011) (57)
- Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial (2022) (55)
- Effectiveness of Common Household Cleaning Agents in Reducing the Viability of Human Influenza A/H1N1 (2010) (54)
- Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective (2011) (54)
- Deposition of respiratory virus pathogens on frequently touched surfaces at airports (2018) (52)
- A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period (2012) (51)
- Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave (2021) (49)
- Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial (2021) (48)
- Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. (2011) (48)
- The first recorded outbreak of cryptosporidiosis due to Cryptosporidium cuniculus (formerly rabbit genotype), following a water quality incident. (2014) (46)
- Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis. (2020) (46)
- Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies (2014) (44)
- Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults (2011) (43)
- Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis. (2017) (43)
- Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. (2010) (43)
- Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge (2022) (40)
- Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3‐15 years and risk factors for infection (2000) (40)
- Excess hospital admissions for pneumonia and influenza in persons [ges ]65 years associated with influenza epidemics in three English health districts: 1987–95 (2001) (40)
- An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998–1999 to 2005–2006 (2010) (39)
- The evolutionary dynamics of influenza A virus adaptation to mammalian hosts (2013) (39)
- Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom (2006) (39)
- Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. (1999) (38)
- Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. (2022) (38)
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial (2022) (38)
- Pandemic ( H 1 N 1 ) 2009 influenza in the UK : clinical and epidemiological findings from the first few hundred ( FF 100 ) cases (2010) (35)
- Effects of seasonal and pandemic influenza on health‐related quality of life, work and school absence in England: Results from the Flu Watch cohort study (2018) (34)
- Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. (2010) (33)
- Vaccination of Health Care Workers to Protect Patients at Increased Risk for Acute Respiratory Disease (2012) (33)
- Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps? (2005) (33)
- A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims (2014) (32)
- The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control. (2016) (31)
- Costs of running a universal adolescent hepatitis B vaccination programme. (2005) (31)
- Influenza vaccination among Australian Hajj pilgrims: uptake, attitudes, and barriers. (2014) (30)
- Differences between asthmatics and nonasthmatics hospitalised with influenza A infection (2012) (30)
- Cohort Profile: The Flu Watch Study (2016) (30)
- Do Influenza Epidemics Affect Patterns of Sickness Absence Among British Hospital Staff? (1999) (30)
- Influenza vaccination for immunocompromised patients: summary of a systematic review and meta‐analysis (2013) (30)
- The Effect of Influenza Virus on the Human Oropharyngeal Microbiome (2018) (28)
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03(A)-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial (2011) (28)
- Family doctor advice is the main determinant of pneumococcal vaccine uptake. (1999) (28)
- The association between benzodiazepines and influenza‐like illness‐related pneumonia and mortality: a survival analysis using UK Primary Care data (2016) (28)
- Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps. (2012) (27)
- General practice and accident and emergency department care: does the patient know best? (1992) (26)
- Adverse medical events in British service personnel following anthrax vaccination. (2003) (26)
- Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus (2021) (24)
- A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence (2019) (24)
- Impact of infection control interventions on rates of Staphylococcus aureus bacteraemia in National Health Service acute hospitals, East Midlands, UK, using interrupted time-series analysis. (2015) (24)
- Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case‐control and survival analysis using the United Kingdom Clinical Practice Research Datalink (2015) (24)
- Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. (2015) (23)
- Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review (2013) (23)
- Influenza vaccination coverage rates in the UK: a comparison of two monitoring methods during the 2002-2003 and 2003-2004 seasons. (2006) (23)
- Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study (2021) (23)
- Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial (2022) (22)
- Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment (2019) (21)
- Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (2018) (21)
- Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine (2021) (21)
- Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region. (2012) (21)
- Oseltamivir resistance in influenza A (H5N1) infection. (2006) (21)
- Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: A case-control study (1999) (21)
- Public Understanding of Pandemic Influenza, United Kingdom (2006) (20)
- Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany (2019) (20)
- What happens to medical students who complete an honours year in public health and epidemiology? (2001) (19)
- Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink (2019) (19)
- Increased risk of A(H1N1)pdm09 influenza infection in UK pig industry workers compared to a general population cohort (2016) (19)
- The Comparative Clinical Course of Pregnant and Non-Pregnant Women Hospitalised with Influenza A(H1N1)pdm09 Infection (2012) (19)
- Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) (2019) (18)
- Prospective study of incidence of Crohn's disease in northwest England: no increase since the late 1970's (1994) (18)
- Co-Infections, Secondary Infections, and Antimicrobial Usage in Hospitalised Patients with COVID-19 from the ISARIC WHO CCP-UK Study: A Prospective, Multicentre Cohort Study (2021) (17)
- Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection (2019) (17)
- Hidden impact of paramedic interventions. (1996) (16)
- Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial (2022) (15)
- Influenza C Virus Infection in Children, Spain (2006) (15)
- Author Correction: Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (2019) (15)
- Protective efficacy of BCG vaccine against leprosy in southern Malaŵi (1993) (15)
- Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol (2021) (14)
- Phylogenetic analysis of multiple heterosexual transmission events involving subtype b of HIV type 1. (2001) (14)
- Practices and policies for influenza immunization in old people's homes in Nottingham (UK) during the 1992-1993 season: potential for improvement. (1995) (14)
- Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial (2022) (14)
- Influenza and other respiratory viruses surveillance in the United Kingdom: October 2003 to May 2004 (2004) (14)
- Unmasking masks in Makkah: preventing influenza at Hajj. (2012) (14)
- Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control. (2000) (14)
- Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs (2020) (14)
- Practical prevention of nosocomial influenza transmission, 'a hierarchical control' issue. (2015) (13)
- Comparison of CATs, CURB-65 and PMEWS as Triage Tools in Pandemic Influenza Admissions to UK Hospitals: Case Control Analysis Using Retrospective Data (2012) (13)
- Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report (1999) (13)
- Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic (2013) (13)
- Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain (2005) (12)
- Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study (2018) (12)
- Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units. (2007) (12)
- Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03A-Adjuvanted H1N1 2009 Vaccine (2013) (12)
- From the Editor's desk (2015) (12)
- What happens to medical students who complete an honours year in public health and epidemiology (2001) (11)
- Antivirals for influenza: where now for clinical practice and pandemic preparedness? (2014) (11)
- Avian influenza and the threat of the next human pandemic (2007) (11)
- A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart. (2010) (11)
- Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK (2014) (11)
- Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC WHO Clinical Characterisation Protocol prospective multicentre observational cohort study (2020) (10)
- Zanamivir for influenza: a public health perspective (1999) (10)
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study (2022) (10)
- Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19 (2020) (9)
- Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis (2021) (9)
- Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality. (2014) (9)
- Use of Antiviral Drugs to Reduce Household Transmission of Pandemic (H1N1) 2009, United Kingdom (2011) (9)
- Minimum dataset for confirmed human cases of influenza H5N1 (2008) (9)
- Recommendations for good practice in pandemic preparedness: identified through evaluation of the response to pandemic (H1N1) 2009. (2010) (9)
- Adolescents' desires and beliefs about motorcycling: implications for education (1985) (9)
- Effectiveness of ambulance paramedics versus ambulance technicians in managing out of hospital cardiac arrest. (1997) (9)
- Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries (2022) (8)
- Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves (2022) (7)
- Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study (2021) (7)
- An alternative AUG codon that produces an N-terminally extended form of the influenza A virus NP is a virulence factor for a swine-derived virus (2019) (7)
- Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia (2021) (7)
- An alternative AUG codon in segment 5 of the 2009 pandemic influenza A virus is a swine-derived virulence motif (2019) (6)
- Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study (2020) (6)
- Health care experiences of Vietnamese families in Nottingham. (1995) (6)
- Reply: Letter to the editor, Cochrane rearranged. (2015) (5)
- "Late presenters" after paracetamol self poisoning. (1998) (5)
- Invasive meningocccal disease among university undergraduates association with catered halls of residence (1999) (5)
- Cumulative incidence of post‐infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis (2020) (5)
- Intervention strategies for emerging respiratory virus infections: policy and public health considerations (2013) (5)
- Pandemic preparedness and response (2013) (5)
- An Evaluation of Community Assessment Tools (CATs) in Predicting Use of Clinical Interventions and Severe Outcomes during the A(H1N1)pdm09 Pandemic (2013) (5)
- Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017 (2021) (5)
- Capecitabine monotherapy in metastatic colorectal cancer. (2001) (4)
- Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness (2018) (4)
- Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic. (2011) (4)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2021) (4)
- Non‐steroidal anti‐inflammatory drugs and appendicitis in patients aged over 50 years (1993) (4)
- Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on “flawed” analysis (2014) (4)
- Who dies from hernia? (1998) (4)
- Deficiencies in undergraduate and pre-registration medical training in prescribing for pain controlShort Communication (1995) (3)
- A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during an influenza pandemic (2019) (3)
- Molnupiravir for SARS-CoV-2 infection: Public health and policy implications (2022) (3)
- Uptake of influenza vaccine (1994) (3)
- Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience (2010) (3)
- Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines (2013) (3)
- QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England (2022) (3)
- Administration of time-expired yellow fever vaccine: public health response and results of a serological investigation. (1999) (3)
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (3)
- Impact of outpatient neuraminidase inhibitor treatment on hospitalisation in patients infected with influenza A (H1N1)pdm09: An IPD analysis (2016) (2)
- Age is not only criterion for flu vaccine (1998) (2)
- Preparedness and response to pandemics and other infectious disease emergencies. (2016) (2)
- Teenagers and motorcycles: knowledge and perception of risks (1986) (2)
- Influenza and other respiratory viral infections (2012) (2)
- Doncaster: the public health response to a local cluster of heterosexually acquired HIV infection. (2002) (2)
- Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza (2018) (2)
- Reply to Jones et al. (2017) (2)
- Vietnamese people in study may have had language difficulties (1996) (2)
- BCG vaccine and leprosy (1992) (2)
- Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage. (2016) (2)
- Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage (2017) (1)
- Neuraminidase inhibitors for influenza complications–Authors' reply (2014) (1)
- Evaluation of inter-pandemic influenza vaccine effectiveness during eight consecutive winter seasons in England and Wales in patients with cardiovascular risk factors. (2010) (1)
- Minimal Transmission in an Influenza A (H3N2) Human Challenge-Transmission Model with Exposure Events in a Controlled Environment (2019) (1)
- Evaluation of S/F94 as a proxy for COVID-19 severity (2022) (1)
- Late-breaking abstract: Relationship of asthma to outcome in influenza A/H1N1 2009 infection: FLU-CIN cohort study (2011) (1)
- Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates collected in the UK. (2003) (1)
- Evaluation Of Resource Utilization Among Infants, Young Children And Elderly Patients Diagnosed With Rsv Infection In The United States (2017) (1)
- Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off (2022) (1)
- WHO manual: How to implement seasonal influenza vaccination of health workers (2019) (1)
- Pandemic Infection Control for Critical Care (2008) (1)
- Carriage of neisseria meningitidis in a village community after mass antibiotic and vaccine programmes (1999) (1)
- Is there a synergistic effect between previous and current vaccination against influenza? (1995) (1)
- Responding to bird influenza: past, present and future. (2008) (1)
- of Birmingham Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol (2020) (1)
- Seventeenth Sir Peter Freyer memorial lecture and surgical symposium (1994) (0)
- OP0267 INACTIVATED INFLUENZA VACCINATION DOES NOT ASSOCIATE WITH DISEASE FLARES IN AUTOIMMUNE RHEUMATIC DISEASES: A SELF-CONTROLLED CASE SERIES STUDY USING DATA FROM THE CLINICAL PRACTICE RESEARCH DATALINK (2019) (0)
- Characteristics of Patients Clinically Diagnosed with Respiratory Syncytial Virus Infection in the United States: a Retrospective Database Analysis (2017) (0)
- Vasectomy and prostate cancer: public health implications (1993) (0)
- Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases (2020) (0)
- Vasectomy and prostate cancer: public health implications [letter] (1993) (0)
- Cochrane column. (2014) (0)
- Interpandemic (seasonal) influenza (2016) (0)
- Disease Surveillance and Global Health Security (2014) (0)
- Epidemic and pandemic influenza (2010) (0)
- Rapid large increase in meningococcal carriage rates in first year university students (1999) (0)
- Evaluating Modes of Influenza Transmission (EMIT) data files (2020) (0)
- Oseltamivir Therapy Improves Survival in Critically Ill Patients with Severe Influenza (2019) (0)
- 022 A heterosexual outbreak in Doncaster involving subtype B of HIV‐1: molecular epidemiology as a supplement to contact tracing (2000) (0)
- Immunogenicity and Reactogenicity of BNT162b2 and mRNA1273 COVID-19 Vaccines Given as Fourth Dose Boosters in the COV-BOOST Randomised Trial Following Two Doses of ChAdOx1 nCov-19 or BNT162b2 and a Third Dose of BNT162b2 (2022) (0)
- Minimal transmission in an influenza A (H3N2) human challenge- 5 transmission model within a controlled exposure environment in a controlled environment (2020) (0)
- Influenza outbreaks in elderly care institutions (2000) (0)
- Follow-up questionnaire (2015) (0)
- The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom (2022) (0)
- Linking micro and macro in the UK National Health Service healthcare worker influenza immunisation programme (2013) (0)
- Influenza aerosols in UK hospitals during the influenza H1N1 (2009–10) pandemic: air sampling in the vicinity of patients undergoing WHO-defined aerosol generating procedures (2012) (0)
- Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply (2012) (0)
- Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511] (2023) (0)
- Nguyen-Van-Tam, Jonathan (2017) Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis. Vaccine . ISSN 0264-410X (2017) (0)
- Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return (2022) (0)
- Doctors accepting flu vaccination is the sensible and responsible choice (2011) (0)
- Authors' response (2011) (0)
- Tackling the next influenza pandemic: Ring prophylaxis may prove useful early on, but is unlikely to be effective or practical to implement once the pandemic is established. (2017) (0)
- Logistic Issues and Potential Prescribing Costs Associated with use of Neuraminidase Inhibitors for the Treatment of Influenza in Primary Care (2003) (0)
- Cohort profile Cohort Profile: The Flu Watch Study the Flu Watch Group (2016) (0)
- Influenza vaccines really work? Keeping apart the true from the false. (2015) (0)
- Predictive accuracy of different clinical definitions of influenza in the community setting (2008) (0)
- Pre-existing immunity in human challenge studies of influenza transmission Reply (2012) (0)
- Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial (2023) (0)
- Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines (2023) (0)
This paper list is powered by the following services:
Other Resources About Jonathan Van-Tam
What Schools Are Affiliated With Jonathan Van-Tam?
Jonathan Van-Tam is affiliated with the following schools:
